What is CVE-2019-13157?

CVE-2019-13157 is a high-severity vulnerability in Naver Vaccine, classified under Path Traversal. CVSS score: 7.5/10. Published 2019-11-22.

How severe is CVE-2019-13157?

High severity. CVSS v3 base score is 7.5 out of 10.

Path Traversal in Naver Vaccine

CVE-2019-13157

nsGreen.dll in Naver Vaccine 2.1.4 allows remote attackers to overwrite arbitary files via directory traversal sequences in a filename within nsz archive.

Vulnerability class: Path Traversal (Directory Traversal)

Published 2019-11-22 · last modified 2026-06-17.

CVSS v3 metric

CVSS v3 base score 7.5 (High). Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:H/A:N.

EPSS exploit prediction

EPSS: 0.017 (75.9th percentile), scored 2026-10-09.

Low probability of exploitation in the next 30 days, but still tracked. 76th percentile — 75.9% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.

EPSS over last 30 days · oldest: 0.017 · newest: 0.017 · change: 0.000

Affected products

Naver Vaccine — versions 2.1.4
Naver Corporation Vaccine — versions unspecified

Weakness classification (CWE)

CWE-22 — Path Traversal

References

cve.naver.com/detail/cve-2019-13157 (Vendor Advisory)

Frequently asked questions

What is CVE-2019-13157?: CVE-2019-13157 is a high-severity vulnerability in Naver Vaccine, classified under Path Traversal. CVSS score: 7.5/10. Published 2019-11-22.
How severe is CVE-2019-13157?: High severity. CVSS v3 base score is 7.5 out of 10.